Evidence map›Paper›PMID 32636464›Full record

ArticleBone marrow transplantation2021

Can we cure refractory Hodgkin's lymphoma with transplantation?

Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, Neeraj Saini, Jin Im, Jeremy Ramdial, Issa Khouri, Paolo Anderlini, Uday Popat, Chitra Hosing and 10 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Stefan O CiureaDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sciurea@mdanderson.org.ORCID http://orcid.org/0000-0001-8597-3271
Piyanuch KongtimCenter of Excellence in Applied Epidemiology and Hematopoietic Stem Cell Transplant Program, Thammasat University, Pathumthani, Thailand.
Samer SrourDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neeraj SainiDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jin ImDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jeremy RamdialDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Issa KhouriDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Paolo AnderliniDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Uday PopatDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chitra HosingDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Richard E ChamplinDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4314-5037
Hun J LeeDepartment of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Luis E FayadDepartment of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fredrick B HagemeisterDepartment of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ana M BicaBone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Lavinia LipanBone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Oana CraciunBone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Cristina G JercanBone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Alina Tanase *Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Anca Colita *Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hodgkin DiseaseLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsBone Marrow TransplantationHumansNeoplasm Recurrence, LocalTransplantation, Autologous

Identifiers

PMID32636464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.